Farmakoekonomika : Impact Factor & More
eISSN: 2070-4933pISSN: 2070-4909
Open AccessShare this on:
Key Metrics
CiteScore 
1
SNIP
0.28
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Farmakoekonomika Journal Specifications
| Overview | |
| Publisher | IRBIS LLC |
| Language | Russian |
| Article Processing Charges | RUB 15000 |
| Publication Time | 8 |
| Editorial Review Process | Double anonymous peer review |
| General Details | |
| Language | Russian |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 8 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Copyright Notice |
| License type | CC BY-NC-SA |
| OA statement | Visit website |
View less
Planning to publish in Farmakoekonomika ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Farmakoekonomika
COVID-19-associated coagulopathy and its role in gastroduodenal ulceration
- 7 Oct 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Evaluation of high-technology medicines considering budget impact and societal value: a three-tier approach using incretin-based therapy as an example
- 5 Oct 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Content analysis of the range of anthelmintic drugs on the pharmaceutical market of the Republic of Uzbekistan, 2016–2025
- 1 Oct 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Assessment of the need for sodium-glucose cotransporter 2 inhibitors in the Republic of Uzbekistan
- 28 Sep 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Comparative analysis of artificial intelligence-enabled medical devices in the state registries of the USA, China, and Russia
- 28 Aug 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Pharmaceutical market for bone resorption inhibitors in Uzbekistan: structure, trends, and pricing aspects
- 28 Aug 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
COVID-19-associated coagulopathy and its role in gastroduodenal ulceration
- 7 Oct 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Evaluation of high-technology medicines considering budget impact and societal value: a three-tier approach using incretin-based therapy as an example
- 5 Oct 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Content analysis of the range of anthelmintic drugs on the pharmaceutical market of the Republic of Uzbekistan, 2016–2025
- 1 Oct 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Assessment of the need for sodium-glucose cotransporter 2 inhibitors in the Republic of Uzbekistan
- 28 Sep 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Comparative analysis of artificial intelligence-enabled medical devices in the state registries of the USA, China, and Russia
- 28 Aug 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Pharmaceutical market for bone resorption inhibitors in Uzbekistan: structure, trends, and pricing aspects
- 28 Aug 2026
- FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
FAQs on Farmakoekonomika
How many articles did Farmakoekonomika publish last year? 
What is the eISSN & pISSN for Farmakoekonomika?
What is Citescore for Farmakoekonomika?
What is SNIP score for Farmakoekonomika?
Who is the publisher of Farmakoekonomika?
